BACKGROUND Neonatal encephalopathy is a clinical condition of altered neurological function in the first days of life. Targeted temperature management (TTM) is a validated approach to mitigate neurologic sequelae. Current literature suggests using rectal or esophageal site to assess temperature during TTM, but few studies focused on the best and the less invasive site to evaluate the temperature. This case report describes the performance of the bladder temperature monitoring during TTM. CLINICAL FINDINGS A female newborn was born at 39 weeks' gestational age plus 4 days. At delivery, the newborn was in cardiorespiratory arrest. PRIMARY DIAGNOSIS After performing cardiopulmonary resuscitation and neurological examination, a hypoxic-ischemic encephalopathy was diagnosed. INTERVENTIONS After about 2 hours from birth, the newborn underwent TTM. OUTCOMES A total of 4642 measurements of rectal temperature and 4520 measurements of bladder temperature were collected. Agreement between the 2 sites was statistically significant with a mean difference of 0.064°C ± 0.219 (95% confidence interval, -0.364 to 0.494); F = 47.044; and P value of less than .001. Furthermore, difference between rectal and bladder sites was not influenced by patient's urine output ( F = 0.092, P = .762). PRACTICE RECOMMENDATIONS Bladder temperature seems to have a good reliability and not to be inferior to the other assessment site currently used. Using bladder catheter with temperature sensor could reduce the number of devices, ensure safer stabilization, and decrease treatment downtime.

中文翻译：

---

新生儿目标温度管理期间的膀胱温度：病例报告。

背景技术新生儿脑病是生命最初几天神经功能改变的临床病症。目标温度管理 (TTM) 是一种经过验证的减轻神经系统后遗症的方法。目前的文献建议在 TTM 期间使用直肠或食管部位来评估温度，但很少有研究关注评估温度的最佳和侵入性较小的部位。本病例报告描述了 TTM 期间膀胱温度监测的性能。临床结果 一名女性新生儿在孕龄 39 周加 4 天时出生。分娩时，新生儿处于心肺骤停状态。初步诊断经过心肺复苏和神经系统检查，诊断为缺氧缺血性脑病。干预措施 出生后约 2 小时后，新生儿接受了 TTM。结果 总共收集了 4642 次直肠温度测量值和 4520 次膀胱温度测量值。2 个地点之间的一致性具有统计显着性，平均差异为 0.064°C ± 0.219（95% 置信区间，-0.364 至 0.494）；F = 47.044；P 值小于 0.001。此外，直肠和膀胱部位之间的差异不受患者尿量的影响（F = 0.092，P = .762）。实践建议 膀胱温度似乎具有良好的可靠性，并不逊色于当前使用的其他评估站点。使用带有温度传感器的膀胱导管可以减少设备数量，确保更安全的稳定性，并减少治疗停机时间。